Accera, a clinical-stage biotech developing treatments for central nervous system disorders, has appointed Judith Walker to its chief medical officer position. Before joining Boulder, CO-based Accera, Walker was vice president of product development at QuintilesIMS (NYSE: [[ticker:Q]]), where her responsibilities included neurology and pain drugs. Walker’s experience also includes posts at Teva Pharmaceutical (NYSE: [[ticker:TEVA]]) and Serono International.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
